TerminatedPhase 1NCT01282333

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

Studying Carcinoma of gallbladder and extrahepatic biliary tract

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Leonard Appleman, MD
University of Pittsburgh
Intervention
gemcitabine hydrochloride(drug)
Enrollment
44 enrolled
Eligibility
18 years · All sexes
Timeline
2011

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01282333 on ClinicalTrials.gov

Other trials for Carcinoma of gallbladder and extrahepatic biliary tract

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of gallbladder and extrahepatic biliary tract

← Back to all trials